Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pembrolizumab Prior to Surgery for Stage 1B, 2 or 3A Non-small Cell Lung Cancer (NSCLC): A Phase II Study

NCT02818920 is registered in ClinicalTrials.gov with Neal Ready MD PhD as lead sponsor.

NCT NCT02818920
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02818920 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pembrolizumab Prior to Surgery for Stage 1B, 2 or 3A Non-small Cell Lung Cancer (NSCLC): A Phase II Study
Lead sponsor
Neal Ready MD PhD
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2017
Completion date
June 20, 2024
Enrollment
35 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

non-small cell lung carcinoma